Marks & Spencer: the retailer rose today, extending a rally from yesterday when its results beat forecasts

Global equity markets bounced, paced by a jump in oil prices today, but were still on track for a weekly decline. The Iseq rose as stocks on Wall St(...)

Inside the Federal Reserve  in Washington. Photograph:  EPA/SHAWN THEW

Anxiety regarding Federal Reserve plans caused stocks to retreat last week – or so we’re told. The Fed recently left rates unchanged and signalled two(...)

Limiting the downside doesn’t mean investors can’t enjoy decent upside, according to David Conlon of Merrion Investment Managers

Like hedge funds, absolute return funds aim to protect investors from the serious downside associated with difficult market environments. But limiting(...)

Traders work on the floor of the New York Stock Exchange. Photograph: EPA/Justin Lane

Hedge funds prove to be a suckers’ bet Ray Dalio of Bridgewater Associates has replaced George Soros as the all-time top-earning hedge fund manager, a(...)

The hedge fund of Bill Ackman has sold some of its shares in Valeant Pharmaceuticals, the embattled drug company that Mr Ackman earlier in 2015 went t(...)

Janet Yellen, chairman of the US Federal Reserve: Recent strong jobs numbers mean a December rate hike now looks a safe bet. Photograph: Joshua Roberts/Reuters

Investors have spent 2015 fretting as to whether the Federal Reserve would finally raise US interest rates and if so, when. Less attention has been pa(...)

Traders work on the floor of the New York Stock Exchange underneath a board showing the name of Valeant Pharmaceuticals shortly before the opening of the markets in New York October 22, 2015.  REUTERS/Lucas Jackson

Investors often say they learn more from investment losers than from winners. That suggests that Valeant, the beleaguered pharmaceutical company whose(...)

Valeant Pharmaceuticals, the Canadian drugmaker known for its serial acquisitions, reported first-quarter profit that topped analysts’ estimates and r(...)

Former Enron chairman Kenneth Lay: short-sellers tend to get a bad press but their defenders point to their exposure of questionable practices at companies like Enron. Photograph: Dave Einsel/Getty Images

Short-sellers profit from market declines, something that has long ensured their unpopularity with politicians, regulators and chief executives. Napol(...)

Traders  on the floor of the New York Stock Exchange. Photograph: Jewel Samad/AFP/Getty Images

Volatility, it appears, is back. After two years of remarkable calm, investor jitters have returned. It’s not simply that stocks are declining; there (...)